44th week of 2009 patent applcation highlights part 35 |
Patent application number | Title | Published |
20090269231 | Method of Pumping Gas - A method of pumping a gas stream containing a condensable species and a light gas and an apparatus therefore, the method comprising the steps of conveying the gas stream to a multistage vacuum pump comprising an inlet stage and an exhaust stage downstream from the inlet stage, and adding to the gas stream upstream of or at the inlet stage a purge gas heavier than said light gas to both inhibit migration of the light gas from the exhaust stage towards the inlet stage and to inhibit condensation of the condensable species within the pump. | 2009-10-29 |
20090269232 | Variable Displacement Vane Pump With Enhanced Discharge Port - A variable displacement vane pump which includes an enhanced discharge port. The enhanced discharge port reduces areas of high pressure in the discharge port which would otherwise occur as the pressurized working fluid reverses its direction of flow to enter the discharge port. By reducing the areas of high pressure, the back torque on the pump rotor is reduced and the energy efficiency of the pump is enhanced. In one embodiment, the pivot for the pump control ring is located radially outwardly from a conventional location, to allow for a discharge recess to be formed in the control ring, adjacent the discharge port, and extending past the pivot to the pump outlet. In a second embodiment, the discharge recess is formed in the control ring around the pivot and a seal is provided on the control ring to inhibit leakage of pressurized working fluid past the control ring. In a third embodiment, a secondary discharge port is provided adjacent the discharge recess formed in the control ring and pressurized working fluid in the discharge recess can exit the discharge recess through the secondary discharge port which is in fluid communication with the pump outlet. | 2009-10-29 |
20090269233 | Variable displacement vane pump - A variable displacement vane pump includes a first and a second fluid pressure chamber ( | 2009-10-29 |
20090269234 | IMPELLER - An impeller for a vane cell pump includes, but is not limited to vane receptacles for receiving an at least radially movable pump vane. A chamber wall is formed between two adjacent vane receptacles to form a conveying chamber. The chamber wall has an axially projecting web for delimiting a movement of a position ring with respect to the radial movement of the pump vane. The chamber wall includes, but is not limited to a first wall region for secure receiving of the respective pump vane in the vane receptacle. The chamber wall further includes, but is not limited to a second wall region for forming a web thickness d of the web for secure abutment of a sintering tool. In addition, the chamber wall has a third wall region for forming an enlarged conveying chamber volume. As a result, the impeller is easily manufactured and has an enlarged pump capacity for the same installation space. | 2009-10-29 |
20090269235 | Production method for sintered machine components - A production method for sintered machine components, includes preparing an Fe alloy powder A, an Fe alloy powder B, an Fe—P powder, and a graphite powder. The Fe alloy powder A consists of, by mass %, 25 to 45% of Cr, 1.0 to 3.0% of Mo, 1.0 to 3.0% of Si, 0.5 to 1.5% of C, and the balance of Fe and inevitable impurities. The Fe alloy powder B consists of, by mass 15 to 35% of Cr, 15 to 30% of Ni, and the balance of Fe and inevitable impurities, and the Fe—P powder consists of 10 to 30 mass % of P and the balance of Fe and inevitable impurities. The production method further includes mixing 40 to 60 mass % of the Fe alloy powder B, 1.0 to 5.0 mass % of the Fe—P powder, and 0.5 to 3.5 mass % of the graphite powder with the Fe alloy powder A into a mixed powder. The production method further includes compacting the mixed powder into a green compact and sintering the green compact. | 2009-10-29 |
20090269236 | DUCTILE MAGNESIUM ALLOY - The present invention relates to a corrosion resistant magnesium alloy which can be prepared with a justifiable expenditure of energy from scrap or impure copper containing precursors and displays a ductility such that it can be used as a casting or kneading material. The magnesium alloy contains, relative to the total weight of the magnesium alloy, 1 to 9 wt. % aluminium, 0.6 to 6 wt. % zinc, 0.1 to 2 wt. % manganese, 0 to 2 wt. % rare earth elements, 0.5 to 2 wt. % copper, wherein the weight ratio of aluminium to zinc lies in the range from 1:1 to 2:1. | 2009-10-29 |
20090269237 | HIGH-STRENGTH NON-COMBUSTIBLE MAGNESIUM ALLOY - The high-strength non-combustible magnesium alloy is obtained by adding at least one supplementary additive selected from among carbon (C), molybdenum (Mo), niobium (Nb), silicon (Si), tungsten (W), alumina (Al | 2009-10-29 |
20090269238 | Nickel material for chemical plant - A nickel material, which comprises by mass percent, C: 0.003 to 0.20% and one or more elements selected from Ti, Nb, V and Ta: a total content less than 1.0%, the contents of these elements satisfying the relationship specified by the formula of “( 12/48)Ti+( 12/93)Nb+( 12/51)V+( 12/181)Ta—C≧0”, with the balance being Ni and impurities, does not deteriorate in the mechanical properties and corrosion resistance even when it is used at a high temperature for a long time and/or it is affected by the heat affect on the occasion of welding. Therefore, it can be suitably used as a member for use in various chemical plants including facilities for producing caustic soda, vinyl chloride and so on. Each element symbol in the above formula represents the content by mass percent of the element concerned. | 2009-10-29 |
20090269239 | Process for Production of Aluminum Ingots, Aluminum Ingots, and Protective Gas for the Production of Aluminum Ingots - To provide a method for producing an aluminum ingot whose oxides is reduced by preventing the surface of molten aluminum from being oxidized. The method according to the present invention includes a melting step (melting furnace | 2009-10-29 |
20090269240 | Fluid Purification Device and Fluid Purification Method - A fluid purification device capable of exerting high disinfection/purification functions by a simple structure is provided, and a fluid purification device capable of suppressing, for example, generation of noise and high-voltage charging upon disinfection/purification of a fluid to be treated composed of liquid such as water is provided. | 2009-10-29 |
20090269241 | Method for removing mercury in exhaust gas and system therefor - The present invention provides a method for removing mercury in exhaust gas, in which mercury in exhaust gas discharged from combustion equipment is removed, characterized by including a mercury oxidation process in which mercury in the exhaust gas is converted to mercury chloride in the presence of a catalyst; a contact process in which the exhaust gas is brought into contact with an absorbing solution in a scrubber to absorb and remove mercury components from the exhaust gas; and a control process in which blowing of air or addition of an oxidizing agent into the scrubber is accomplished, and the amount of blown air or the added amount of oxidizing agent is regulated to control the oxidation-reduction potential of the absorbing agent, and a system for removing mercury in exhaust gas. According to the mercury removing method in accordance with the present invention, a phenomenon that mercury chloride is reduced into metallic mercury by SO | 2009-10-29 |
20090269242 | ANALYZER - An analyzer includes a management unit that manages initiation timings of a calibration analysis process, in which a calibrator is analyzed, and a blank analysis process, in which a blank sample is used, independently for each of the analytical items. The management unit performs at least the blank analysis process before an expiration date for managing accuracy of a result of the blank analysis and when a reagent is supplied, and the management unit performs the calibration analysis process before an expiration date for managing accuracy of a result of the calibration analysis and when the reagent is supplied. | 2009-10-29 |
20090269243 | ELECTRICALLY CONTROLLED MICROFLUIDIC SYSTEM - An electrically controlled microfluidic system ( | 2009-10-29 |
20090269244 | Detection of biochemical interactions on a biosensor using tunable filters and tunable lasers - An apparatus and method for detection of peak wavelength values of colorimetric resonant optical biosensors using tunable filters and tunable lasers is provided. Biomolecular interactions may be detected on a biosensor by directing collimated white light towards a surface of the biosensor. Molecular binding on the surface of the biosensor is indicated in a shift in the peak wavelength value of the reflected or transmitted light from the biosensor, while an increase in the wavelength corresponds to an increase in molecular absorption. A tunable laser light source may generate the collimated white light and a tunable filter may receive the reflected or transmitted light and pass the light to a photodiode sensor. The photodiode sensor then quantifies an amount of the light reflected or transmitted through the tunable filter as a function of the tuning voltage of the tunable filter. | 2009-10-29 |
20090269245 | MICRO FLUID SYSTEM SUPPORT AND MANUFACTURING METHOD THEREOF - A support unit for a microfluidic system includes a first support; a first adhesive layer provided on a surface of the first support; and a hollow filament laid on a surface of the first adhesive layer to have an arbitrary shape and functioning as a flow channel layer of the microfluidic system. | 2009-10-29 |
20090269246 | Specimen sampling liquid container - A specimen sampling liquid container which eliminates the risk of an inspector being contaminated or infected with a virus and the drawback of troublesome workability. The specimen sampling liquid container comprises a bottomed tubular container having an open upper end, a sealing member for closing the opening in the tubular container, and a cap provided with a member engaging with the upper end of the tubular container at a first position, capable of being moved from the first position to a second position, receiving the sealing member, having a drip opening at the upper end, and releasing the sealing member to below the drip opening, wherein the sealing member for closing the opening in the tubular container is released when the cap is slid from the first position to the second position, thus allowing the drip opening of the cap and the tubular container to communicate with each other. | 2009-10-29 |
20090269247 | FLUID COLLECTION DEVICE WITH EXPRESSER PLUG HOLDER - A fluid collection device has a collection vial with a reservoir chamber for receiving a fluid sample. An elongated expresser is disposed within the collection via, which includes a fluid permeable base enabling passage of fluid sample into the reservoir chamber. A fluid test card is supported by an expresser bottom flange within the collection vial and a plunger is provided for compression of a swab saturated with fluid specimen into the reservoir chamber. A cap is provided for engaging the collection vial in order to seal the compressor, fluid test card, compressed swab, and plunger within the collection vial. | 2009-10-29 |
20090269248 | METHOD AND APPARATUS FOR ANALYTE PROCESSING - A system for processing analytes in samples includes an instrument and a cartridge. The cartridge includes fluid inputs, input and output valve assemblies, processing devices, fluid reservoirs, and channels for carrying samples from the fluid inputs to the fluid reservoirs. The valve assemblies include valves adapted to form a sealed fluid chamber in response to force applied by a movable head assembly of the instrument. Each fluid reservoir is adapted to mate and align with an air displacement pump interface member. A valve assembly includes a recess wall surrounding a recess and a valve assembly wall surrounding both the recess and the recess wall. The recess wall and the valve assembly walls are adapted to mate with and seal against a flexible sheet covering the recess, the recess wall, and the valve assembly wall. The cartridge and instrument include complementary features for finely and coarsely aligning instrument assemblies with portions of the cartridge. | 2009-10-29 |
20090269249 | Allergen inactivating method, allergen inactivating filter, air treating apparatus, virus inactivating agent, virus inactivating method, virus inactivating filter, air conditioning unit and air conditioner - The invention provides an allergen inactivating method by maintaining the allergens under a condition in which any one selected from the group consisting of heat, an alkali, an acid and an enzyme exists. | 2009-10-29 |
20090269250 | Apparatus and Methods For Nanoparticle Generation and Process Intensification of Transport and Reaction Systems - Apparatus, systems and methods are provided that utilize microreactor technology to achieve desired mixing and interaction at a micro and/or molecular level between and among feed stream constituents. Feed streams are fed to an intensifier pump at individually controlled rates, e.g., based on operation of individually controlled feed pumps. The time during which first and second feed streams are combined/mixed prior to introduction to the microreactor is generally minimized, thereby avoiding potential reactions and other constituent interactions prior to micro- and/or nano-scale interactions within the microreactor. Various microreactor designs/geometries may be employed, e.g., “Z” type single or multi-slot geometries and “Y” type single or multi-slot geometries. Various applications benefit from the disclosure, including emulsion, crystallization, encapsulation and reaction processes. | 2009-10-29 |
20090269251 | MICROREACTOR - Disclosed herein is a microreactor capable of reducing a pressure drop in an entire system. | 2009-10-29 |
20090269252 | Operation of catalyst withdrawal wells with packing - An improved fluidized catalyst withdrawal well containing packing or other structured internals is disclosed for improving the flow of particular solids between two apparatus, such as between a catalyst regenerator and riser reactor. | 2009-10-29 |
20090269253 | HYDROGEN SULFIDE PRODUCTION-SUPPRESSING MEMBER AND EXHAUST GAS-PURIFYING CATALYST - Disclosed herein is a hydrogen sulfide production-suppressing member, comprising: a sulfur-adsorbing portion | 2009-10-29 |
20090269254 | HOLDING SEALING MATERIAL, METHOD FOR MANUFACTURING HOLDING SEALING MATERIAL, AND EXHAUST GAS PURIFYING APPARATUS - A holding sealing material includes a plurality of mats. The plurality of mats have a longitudinal direction and include a lower mat and an upper mat laminated on the lower mat. Each of the plurality of mats includes inorganic fibers and has a substantially rectangular shape. A length of the lower mat in the longitudinal direction is longer than a length of the upper mat in the longitudinal direction. Each of the plurality of mats is connected to each other at at least two fixed portions. The at least two fixed portions are positioned at different positions in the longitudinal direction. | 2009-10-29 |
20090269255 | HOLDING SEALING MATERIAL, METHOD FOR MANUFACTURING HOLDING SEALING MATERIAL, AND EXHAUST GAS PURIFYING APPARATUS - A holding sealing material includes mats which have a longitudinal direction and first and second longer side faces along the longitudinal direction and which include a lower mat and an upper mat laminated on the lower mat. A length of the lower mat in the longitudinal direction is longer than a length of the upper mat in the longitudinal direction. Each of the mats is connected to each other at a fixed portion which extends substantially along a width direction perpendicular to the longitudinal direction. The fixed portion has first and second end portions in the width direction. The first end portion is on a side of the first longer side face. The second end portion is on a side of the second longer side face. The first and second end portions are spaced apart from the first and second longer side face, respectively. | 2009-10-29 |
20090269256 | ELECTROSTATIC COALESCING DEVICE - An electrical appliance including at least one sheet-shaped electrode and a connecting device for electrically connecting the at least one electrode to a voltage source. The connecting device includes a casing having two or more tubular casing parts. Each casing part enclosing a channel filled with a dielectric medium, and an elongated conductor for feeding electric power from the voltage source to the at least one electrode. The conductor extends through the channels of the casing parts and is surrounded by the dielectric medium therein. The conductor extends through a hole in an electrically conductive member of each individual electrode. The conductor is electrically connected to the conductive members of the electrodes and each individual electrode has a part arranged between two of the casing parts with the two casing parts clamped against opposite sides of the intermediate electrode part. | 2009-10-29 |
20090269257 | APPARATUS FOR SYNTHESIZING A SINGLE-WALL CARBON NANOTUBE ARRAY - An apparatus for synthesizing a single-wall carbon nanotube array, includes a reactor, a local heating device, a gaseous carbon supplier, and a reactant gas supplier. The reactor includes a reaction zone receiving a catalyst. The local heating device is configured for focusing heat at reaction zone and/or the catalyst. The gaseous carbon supplier is configured for introducing gaseous carbon into the reactor from an upstream position of the reaction zone. The reactant gas supplier is configured for introducing a reactant gas containing a carbon source gas into the reactor. | 2009-10-29 |
20090269258 | A CATALYTIC REACTION DEVISE - A catalytic reaction device for fluid-solid heterogeneous catalytic reactions including a distributor, flow controllers, parallel reactors, temperature controllers, coolers and product receivers with reactive fluids flowing into the flow controllers to control the total flow of a fluid is provided. | 2009-10-29 |
20090269259 | Apparatus for Producing Trichlorosilane - An apparatus for producing trichlorosilane, including: a reaction vessel in which a supply gas containing silicon tetrachloride and hydrogen is supplied to an internal reaction passageway to produce a reaction product gas containing trichlorosilane and hydrogen chloride; a heating mechanism that heats the interior of the reaction vessel; a gas supply section that supplies the supply gas in the reaction vessel; and a gas discharge section that discharges the reaction product gas from the reaction vessel to the outside, wherein the reaction passageway includes: a supply side passageway which is connected to the gas supply section at a central portion of the reaction vessel and flows the supply gas toward the outside while meandering in the reaction vessel; a return passageway which is connected to a downstream end of the supply side passageway and extends to the central portion of the reaction vessel; and a discharge side passageway that is disposed so as to be connected to a downstream end of the return passageway and to adjoin the supply side passageway of the central portion of the reaction vessel, the discharge side passageway being connected to the gas discharge section. | 2009-10-29 |
20090269260 | METHOD AND APPARATUS FOR FINE SOLIDS RECYCLE - A fine solids recycle apparatus for a fluidized bed reactor comprises an eductor connected to a dipleg extending from a cyclone connected to the reactor, wherein the fine solids particles are removed from the dipleg, mixed with an eductor gas to form an eductor gas-fine solids particles mixture, which allows the return of the fine solids particles to the fluidized bed region, whereby the fine solids is further reacted in the fluidized region to improve reaction efficiency. | 2009-10-29 |
20090269261 | Process for Recovering Isolated Uranium From Spent Nuclear Fuel Using a Highly Alkaline Carbonate Solution - Disclosed is a process for recovery of uranium from a spent nuclear fuel using a carbonate solution, characterized by excellent proliferation resistance of preventing leaching of transuranium element (TRU) nuclides such as Pu, Np, Am, Cm, etc. from the spent nuclear fuel as well as environmental friendliness of minimizing waste generation, wherein a highly alkaline carbonate solution is used to separate uranium alone from the spent nuclear fuel. | 2009-10-29 |
20090269262 | AIR POLLUTANT CONTROL SYSTEM AND METHOD FOR REMOVING MERCURY IN FLUE GAS - An air pollutant control system comprises: a denitration apparatus that reduces nitrogen oxide in flue gas discharged from a coal combustion boiler, and that sprays hydrogen chloride into the gas to oxidize mercury, an air heater that recovers heat in gas, a dust collector that reduces dust in gas, a desulfurization apparatus that reduces sulfur oxide in gas from which the dust has been reduced, a hydrogen chloride vaporizer that evaporates concentrated hydrochloric acid to obtain the hydrogen chloride, and a hydrochloric acid neutralization tank where dilute hydrochloric acid discharged from the hydrogen chloride vaporizer or the concentrated hydrochloric acid is neutralized with an alkali agent. Neutralized chloride is supplied to a fuel feeder, mixed with a fuel, and then burned as a fuel in a boiler to produce hydrogen chloride in flue gas. Together with sprayed hydrogen chloride derived from the hydrogen chloride vaporizer, the mercury is reduced. | 2009-10-29 |
20090269263 | Gas Processing for Catalytically Oxidizing Carbon Monoxide and Hydrocarbons In the Presence of a Metal/Silica-Containing Zirconia Catalyst - The processing of gases, in particular the exhaust gas of an internal combustion/diesel engine, entails catalytically oxidizing the carbon monoxide and hydrocarbons contained therein in an oxygen-rich medium, in the presence of a metal oxidation catalyst that includes a silica-containing zirconia support. | 2009-10-29 |
20090269264 | Carbon Dioxide Reforming Catalyst and Method for Manufacturing the Same - A carbon dioxide reforming catalyst and a manufacturing method thereof are provided, the catalyst enabling a hydrocarbon feedstock gas to react with carbon dioxide while carbon deposition is suppressed, efficiently generating hydrogen and carbon monoxide. A mixture containing a carbonate of at least one alkaline earth metal selected from the group consisting of Ca, Sr, and Ba and a catalytic metal promoting a decomposition reaction of a hydrocarbon feedstock gas is contained as a primary component. The catalytic metal can be a least one element selected from the group consisting of Ni, Rh, Ru, Ir, Pd, Pt, Re, Co, Fe, and Mo. In addition, ATiO | 2009-10-29 |
20090269265 | Exhaust gas purification method using selective reduction catalyst - An exhaust gas purification method which is capable of purifying nitrogen oxide to be included in exhaust gas from a lean burn engine such as a boiler, a gas turbine or a lean-burn-type gasoline engine, a diesel engine, effectively, in particular, even at low temperature, with spray-supplying an aqueous solution of urea as the reducing component to the selective reduction catalyst. | 2009-10-29 |
20090269266 | Oxidic Metal Composition, Its Preparation And Use As Catalyst Composition - Oxidic composition consisting essentially of oxidic forms of a first metal, a second metal, and optionally a third metal, the first metal being either Ca or Ba and being present in the composition in an amount of from about 5 to about 80 wt %, the second metal being Al and being present in the composition in an amount of from about 5 to about 80 wt %, the third metal being selected from the group consisting of La, Ti, and Zr, and being present in an amount of from 0 to about 17 wt %—all weight percentages calculated as oxides and based on the weight of the oxidic composition, the oxidic composition being obtainable by | 2009-10-29 |
20090269267 | Continuous method and apparatus for functionalizing carbon nanotube - The present invention relates to a continuous method and apparatus for functionalizing a carbon nanotube, and more specifically, to a continuous method and apparatus for functionalizing a carbon nanotube including preparing a functionalized product by functionalizing a carbon nanotube solution including nitro compound according to the following Chemical Formula 1 and carbon nanotube mixture including an oxidizer for forming nitric acid under subcritical water or supercritical water condition of 50 to 400 atm and a continuous method and apparatus for functionalizing a carbon nanotube under subcritical water or supercritical water condition using nitro compound without using strong acids or strong bases. | 2009-10-29 |
20090269268 | METHOD OF SEPARATING CARBON DIOXIDE FROM GAS MIXTURE USING BIOPOLYMER - Disclosed herein is a method of separating carbon dioxide from a gas mixture using a biopolymer, including: introducing hemocyte or extrapallial fluid, extracted from shells, into a reactor filled with 1L of a solution containing a calcium source, and then dissolving the hemocyte or extrapallial fluid in the solution to form a mixed solution; and mixing carbon dioxide or a gas mixture containing carbon dioxide into the mixed solution to separate carbon dioxide from the gas mixture. | 2009-10-29 |
20090269269 | COPPER OXIDE NANOPARTICLE SYSTEM - The disclosed subject matter provides a copper oxide nanoparticle, a catalyst that includes the copper oxide nanoparticle, and methods of manufacturing and using the same. The catalyst can be used to catalyze a chemical reaction (e.g., oxidizing carbon monoxide (CO) to carbon dioxide (CO | 2009-10-29 |
20090269270 | PROCESS FOR PREPARING CHLORINE IN A FLUIDIZED-BED REACTOR - A process for preparing chlorine in a fluidized-bed reactor, in which a gaseous reaction mixture comprising hydrogen chloride and oxygen flows from the bottom upward through a heterogeneous particulate catalyst forming a fluidized bed, wherein the fluidized bed is provided with internals which divide the fluidized bed into a plurality of cells arranged horizontally in the fluidized-bed reactor and a plurality of cells arranged vertically in the fluidized-bed reactor, with the cells having cell walls which are permeable to gas and have openings which ensure an exchange number of the heterogeneous, particulate catalyst in the vertical direction in the range from 1 to 100 liters/hour per liter of reactor volume, is proposed. | 2009-10-29 |
20090269271 | SEMICONDUCTOR SUBSTRATE FOR EPITAXIAL GROWTH AND MANUFACTURING METHOD THEREOF - Provided is a semiconductor substrate for epitaxial growth which does not require any etching treatment as a pretreatment in the stage of performing an epitaxial growth of HgCdTe film. A CdTe system compound semiconductor substrate for the epitaxial growth of the HgCdTe film is housed in an inactive gas atmosphere, in a predetermined period of time (for example, 10 hours) after mirror finish treatment thereof, to thereby regulate the proportion of Te oxide of the total amount of Te on the substrate surface which is obtained by XPS measurement so as to be not more than 30%. | 2009-10-29 |
20090269272 | PROCESS AND PLANT FOR THE PRODUCTION OF SULPHURIC ACID - The invention relates to a process and plant for producing sulphuric acid by catalytic oxidation of SO | 2009-10-29 |
20090269273 | OXYGEN EXTRACTION APPARATUS AND PROCESS - A facility and process capable of extracting oxygen in extraterrestrial environments from materials available in extraterrestrial environments, for example, on planets, planetoids, etc. The facility extracts oxygen from a mineral-containing solid material and is configured to form a free-falling molten stream of the solid material, evaporate at least a portion of the molten stream and produce a vapor containing gaseous oxygen, create a supersonic stream of the vapor, condense constituents of the supersonic stream to form particulates within the supersonic stream, separate the gaseous oxygen from the particulates, and then collect the gaseous oxygen. | 2009-10-29 |
20090269274 | PRODUCTION METHOD OF LAYERED CRYSTAL MATERIAL - An ammonium metavanadate is heat-treated to 500° C. or less at a predetermined rate of temperature rise, whereby a microcrystal particle of a vanadium pentoxide can be formed. According to the production method described above, a crystal of a nano-vanadium having a layer length of 100 nm or less can be formed. The nano-vanadium formed by the production method described above can effectively be used for an electrode of an electric storage device such as a battery. The production method according to the present invention can be linked to a conventional production method in which an ammonium metavanadate can be formed in the course of the method, whereby the present invention can smoothly be embodied. | 2009-10-29 |
20090269275 | PRODUCING METHOD OF HYDROGEN STORAGE ALLOY - The invention intends to provide a hydrogen storage alloy that can absorb and release hydrogen effectively at room temperature and shows excellent hydrogen storage amount and effective hydrogen transfer amount and furthermore shows excellent endurance. | 2009-10-29 |
20090269276 | PROCESS FOR PRODUCING ZEOLITE SEPARATION MEMBRANE - The present invention provides a process for production of a zeolite separation membrane with satisfactory separation performance. The process for production of a zeolite separation membrane according to the invention is comprising: a seed crystal-attaching step in which: a sealed body ( | 2009-10-29 |
20090269277 | Multivalent Immunoglobulin-Based Bioactive Assemblies - The present invention concerns methods and compositions for stably tethered structures of defined compositions, which may have multiple functionalities and/or binding specificities. Preferred embodiments concern hexameric stably tethered structures comprising one or more IgG antibody fragments and which may be monospecific or bispecific. The disclosed methods and compositions provide a facile and general way to obtain stably tethered structures of virtually any functionality and/or binding specificity. The stably tethered structures may be administered to subjects for diagnostic and/or therapeutic use, for example for treatment of cancer or autoimmune disease. The stably tethered structures may bind to and/or be conjugated to a variety of known effectors, such as drugs, enzymes, radionuclides, therapeutic agents and/or diagnostic agents. | 2009-10-29 |
20090269278 | Radiolabeled Glycine Trasporter Inhibitors - The present invention is directed to radiolabeled glycine transporter inhibitors which are useful for the labeling and diagnostic imaging of glycine transporters in mammals. | 2009-10-29 |
20090269279 | Toxicology and Cellular Effect of Manufactured Nanomaterials - The increasing use of nanotechnology in consumer products and medical applications underlies the importance of understanding its potential toxic effects to people and the environment. Herein are described methods and assays to predict and evaluate the cellular effects of nanomaterial exposure. Exposing cells to nanomaterials at cytotoxic doses induces cell cycle arrest and increases apoptosis/necrosis, activates genes involved in cellular transport, metabolism, cell cycle regulation, and stress response. Certain nanomaterials induce genes indicative of a strong immune and inflammatory response within skin fibroblasts. Furthermore, the described multiwall carbon nanoonions (MWCNOs) can be used as a therapeutic in the treatment of cancer due to its cytotoxicity. | 2009-10-29 |
20090269280 | METHOD FOR ACTIVATION OF TRANSIENT RECEPTOR POTENTIAL CATION CHANNEL, SUBFAMILY A, MEMBER 1 USING ACETALDEHYDE - The present invention relates to a method for activation of TRPA1 (transient receptor potential cation channel, subfamily A, member 1) using acetaldehyde, more precisely a method for selecting a candidate for TRPA1 activation blocker from neurons activated by acetaldehyde. Acetaldehyde of the present invention works on TRPA1 specifically so that it facilitates the isolation of sensory neurons expressing TRPA1. Therefore, acetaldehyde of the invention can be effectively used for the studies on TRPA1 mechanisms and the development of a TRPA1 based anodyne. | 2009-10-29 |
20090269281 | Calcium/Calmodulin-Dependent Protein Kinase Kinase as a Control Point for Cardiac Hypertrophy - The present invention includes compositions and methods for treating a patient with cardiac hypertrophy by providing the patient with an effective amount of a Calmodulin kinase kinase inhibitor that is sufficient to treat cardiac hypertrophy. | 2009-10-29 |
20090269282 | Methods for treating, preventing and diagnosing procine ttv infection - Compositions and methods for treating, preventing and diagnosing Torque teno virus (TTV) infection in pigs are disclosed. Also described are methods of identifying compounds for the treatment and prevention of TTV infection, as well as TTV animal models and methods of producing the same. | 2009-10-29 |
20090269283 | METHOD AND PRODUCT FOR LOCATING AN INTERNAL BLEEDING SITE - A method is provided for localizing an internal bleeding site whereby a protein or other factor involved in the clotting process is complexed to an imaging agent and injected into a patient believed to be at risk of internal bleeding. A clot in the patient will naturally accumulate a certain concentration of the injected complex, and within a short period of time the concentration becomes sufficient to be detected by an imaging apparatus. The imaging contrast agent may, for example, be an MRI contrast agent, a CT contrast agent, a PET agent, or a fluorescent substance. | 2009-10-29 |
20090269284 | CONTRAST AGENTS - The present invention relates generally to multimodal magnetic resonance imaging (MRI) contrast agents. In particular, the present invention provides a MRI contrast agent configured to manipulate both the longitudinal (T | 2009-10-29 |
20090269285 | Diagnostic And Therapeutic Epitope, And Transgenic Plant - A peptide analogue which is not more than 50 amino acids in length, and which is capable of being recognized by a T cell receptor that recognizes an epitope comprising sequence | 2009-10-29 |
20090269286 | SYSTEM AND METHOD FOR AUTHENTICATING PHARMACEUTICALS USING INTERNALLY LOCATED HYDROSCOPIC GELS WITH INDICIA - The invention is an article of manufacture, comprising an identifying marker disposed in a pharmaceutical product. The pharmaceutical product may be selected from the group consisting of a pharmaceutical liquid, a pill, a tablet, a caplet, and a capsule. The identifying marker may be a hydroscopic medium having an indicia imprinted thereon or within, where the marker expands volumetrically when contacted with a liquid. | 2009-10-29 |
20090269287 | Oral Care Compositions - Disclosed are oral care compositions, particularly thickened dentifrices in liquid, paste or gel form comprising a binding/thickening system that also function effectively as humectant agent thereby replacing a significant portion or all of traditional humectant components such as glycerin, sorbitol and other polyols. The binding/thickening system comprise select carrageenans that provide a water viscosity of at least about 20 mPa·s in a 1.5% solution at 25° C. and effective water-binding capacity to prevent significant water loss from the composition when exposed to air to cause unacceptable drying out. For example, the water-binding capacity of the carrageenan must be effective such that there is no more than about 0.75% water loss from a dentifrice composition when exposed to air for 30 minutes at room temperature conditions and 50% relative humidity. The present dentifrice compositions exhibit increased dispersibility in saliva during use, which provides for increased contact time of the composition with the user's teeth and oral cavity tissues such that the active dental agents contained therein are more rapidly available to effect their beneficial activity. | 2009-10-29 |
20090269288 | Black pearl toothpaste - A proposed toothpaste is disclosed providing a synergistic composition for toothpaste to prevent decay, to prevent and control dental plague and gingivitis, and to suppress growth of wide spectrum of micro organisms that cause periodontal disease, while not exhibiting any harmful particular side effect. It allows absorbing and removing odor components out of the oral cavity for a long period of time, removing stain from the teeth, and polishing them. The toothpaste comprises: Sodium Monofluorophosphate, Glycerin, Water, Calcium Carbonate, Xylitol-70%, Sodium Dodecyl Sulfate, Sodium Saccharin, Sodium Bicarbonate, Sodium Methylparaben, Xanthan Gum (E-415), Cellulose Gum (E-466), Hydrated Silica, Titanium Dioxide (E-171), Peppermint Oil, Commiphora Myrrh Extract, Menthol, Charcoal, Grape Seed Oil, and Extract of Brazilian Acai Berry. Particular amounts of weight units for preferred embodiments are provided, as well as a sample method of preparation the toothpaste. | 2009-10-29 |
20090269289 | Use of Tellurium Compounds for Protection from Ultra-Violet Radiation - Methods for treating skin conditions such as basal cell carcinoma and/or actinic keratosis are provided, which are effected by administering a pharmaceutically effective amount of a tellurium-containing compound. A pharmaceutical composition for treatment of skin conditions such as basal cell carcinoma an/or actinic keratosis is also provided. | 2009-10-29 |
20090269290 | Melt formula - A topical composition comprises a vehicle, said vehicle including an emulsion or dispersion of water in an amount of from 50% by weight to 93% by weight; and a non-aqueous discontinuous phase in an amount of from 50% by weight to 7% by weight; at least one of a bronzer, a tanning accelerator, or a mixture thereof; and from 0.01% by weight to 5% by weight of a warming agent, based on the total weight of the composition. The warming agent comprises at least one alkyl ether of vanillyl alcohol at least one N-alkyl amide of vanillic acid; and is present in an amount effective to produce a prolonged warming sensation when applied to a user's skin. The composition is transparent to UV radiation. The composition is used for indoor tanning. | 2009-10-29 |
20090269291 | Protection of Skin from UV and Peroxide - The present invention discloses certain heterocyclic complexes of metals of formula (I), especially those of manganese, which enhance the safety and efficacy of sunscreens via urocanate pathway modulation. The present invention also discloses a method for topical application of said complexes, which causes the reduction of topical peroxide including hydrogen peroxide, the reduction of topical inflammation including sunburn, increased sun protection of skin, comprehensive protection from UVA, UVB, and UVC, reduction of radiation-initiated inflammation, the reduction of skin wrinkles, acne, and overall treatment of skin damaged from natural aging and exposure to sun: | 2009-10-29 |
20090269292 | METHOD FOR MAKING AN EMULSIFIED ANTIPERSPIRANT PRODUCT - Methods for making antiperspirant products that are in the form of emulsions comprising a continuous water-immiscible phase and a disperse aqueous phase. | 2009-10-29 |
20090269293 | Oil-Based Skin Treatment Composition - The invention provides an oil-based skin treatment composition that contains antibacterial zeolite, an oil component, and glutathione and/or L-cysteine. | 2009-10-29 |
20090269294 | Fragrance Precursor - The invention relates to a compound of the following formula (I) X—CR | 2009-10-29 |
20090269295 | AQUEOUS COSMETIC COMPOSITION COMPRISING ONE OR MORE VINYLFORMAMIDE/VINYLAMINE COPOLYMERS, ONE OR MORE NON-SILICONE FATTY SUBSTANCES, ONE OR MORE SURFACTANTS AND ONE OR MORE SILICONES - A cosmetic composition containing in a cosmetically acceptable aqueous medium:
| 2009-10-29 |
20090269296 | Hair Treatment Compositions - A hair treatment composition, comprising a non-emulsified silicone pressure sensitive adhesive dissolved in a volatile solvent. | 2009-10-29 |
20090269297 | MULTIPLE COMPONENT COMPOUND AND METHOD FOR NEUTRALIZING OFFENSIVE ODORS - A multiple component compound containing a molecular encapsulator and an aromatic complex is able to neutralize a wide variety of offensive odors, called malodors. The molecular encapsulator encapsulates molecules of malodors, including those derived from substances with sulfur groups or ammonia groups. The aromatic complex, via charge exchanges, disrupts the bonds of molecules of other malodors, including those derived from substances with fatty acids. Also, the compound may include a fragrance component, which would mask any remaining odor not addressed by the other components and would provide an overall fragrance as is desired. | 2009-10-29 |
20090269299 | Cosmetic Method for use in Smoothing the Skin - The present invention relates to a cosmetic skin care method, in particular for wrinkled skin, comprising the topical application to the skin of a composition comprising, in a physiologically acceptable medium, at least:
| 2009-10-29 |
20090269300 | Anthranilamides for Controlling Invertebrate Pests - Disclosed are compounds of Formula (1), including all geometric and stereoisomers, N-oxides, and salts thereof, wherein R | 2009-10-29 |
20090269301 | Novel Inhibitors of Glutaminyl Cyclase - The present invention relates to compounds of formula (I), combinations and uses thereof for disease therapy, | 2009-10-29 |
20090269302 | HUMAN ANTIBODIES THAT BIND HUMAN IL-12 AND METHODS FOR PRODUCING - Human antibodies, preferably recombinant human antibodies, that specifically bind to human interleukin-12 (hIL-12) are disclosed. Preferred antibodies have high affinity for hIL-12 and neutralize hIL-12 activity in vitro and in vivo. An antibody of the invention can be a full-length antibody or an antigen-binding portion thereof. The antibodies, or antibody portions, of the invention are useful for detecting hIL-12 and for inhibiting hIL-12 activity, e.g., in a human subject suffering from a disorder in which hIL-12 activity is detrimental. Nucleic acids, vectors and host cells for expressing the recombinant human antibodies of the invention, and methods of synthesizing the recombinant human antibodies, are also encompassed by the invention. | 2009-10-29 |
20090269303 | METHOD FOR TREATING OR PREVENTING CONDITIONS BY ELEVATION OF THE ADENOSINE LEVEL IN AN INDIVIDUAL - This invention concerns a method of inducing an elevated level of adenosine in an individual by administering to the individual an effective amount of either i) recombinant protein CD73 or ii) a cytokine or another factor being capable of inducing endothelial CD73 expression, or a combination thereof. In addition, the invention concerns a method for prevention or treatment of a disease or disorder requiring or benefiting from the elevation of the adenosine level in an individual. Furthermore, the invention concerns a method of up-regulating endothelial CD73 expression in an individual by administering to the individual an effective amount of a cytokine or another factor being capable of inducing endothelial CD73 expression, and to a method for prevention or treatment of a disease or disorder requiring or benefiting from up-regulating endothelial CD73 expression. | 2009-10-29 |
20090269304 | METHODS OF TREATING CANCER USING IL-21 AND MONOCLONAL ANTIBODY THERAPY - Methods for treating cancer by co-administering a therapeutic monoclonal antibody with IL-21 are described. Exemplary monoclonal antibodies that can be used are rituximab, trastuzumab and anti-CTLA-4 antibodies. The enhanced antitumor of the combination therapy is particularly useful for patient populations that are recalcitrant to monoclonal therapy, relapse after treatment with monoclonal antibodies or where the enhanced IL-21 antitumor effect reduces toxicities associated with treatment using the monoclonal antibodies. | 2009-10-29 |
20090269305 | NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION - The embodiments provide compounds of the general Formulae I, II, III, IV, V, VI, VII, and X, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition. | 2009-10-29 |
20090269306 | N-TERMINAL MODIFIED INTERFERON-ALPHA - A method of reducing formation of non-natural disulfide bonds in a mature IFN-α by adding one or more amino acid residues to its N-terminus cystein. Also disclosed herein is the IFN-α thus modified. | 2009-10-29 |
20090269307 | Edible Product Containing Ginseng Polysaccharides and Beneficial Bacteria - One aspect of the present invention relates to an edible product containing: • probiotic bacteria in an amount of at least 10 | 2009-10-29 |
20090269308 | Compositions of Keratin Hydrolysate and Microbes for Pest Control Applications - The combination of keratin hydrolysate with viable cells or infectious propagules of a fungal biological control agent such as | 2009-10-29 |
20090269309 | Retinoic acid stimulates differentiation of pancreatic progenitor cells into insulin producing cells - The invention relates to a method of forming pancreatic hormone-producing endocrine cells in vitro, wherein pancreatic stem cells are treated with one or more retinoids and/or retinoic acid in vitro and cultured. Especially the dorsal pancreatic bud is used and to the cells obtained by the method. Further, it relates to the use of the pancreatic hormone-producing endocrine cells, for the production of a pharmaceutical composition for transplantation and/or treatment of type 1 and type 2 diabetes. It also relates to a method for treatment of type 1 and type 2 diabetes by administrating the hormone-producing endocrine cells to individuals in need thereof. The invention also regards the use of one or more retinoids and/or retinoic acid for the differentiation, in vitro of pancreatic stem cells into pancreatic hormone-producing endocrine cells, such as glucagon producing cells, and in particular, insulin producing β-cells. | 2009-10-29 |
20090269310 | METHOD FOR OBTAINING HUMAN SMOOTH MUSCULAR CELLS AND USES THEREOF - The invention concerns a method for obtaining in vitro a population of cells comprising essentially human smooth muscular cells expressing calponin and SM-MHC from a sample of human muscular biopsy or from human muscular biopsies differentiated in vitro into skeletal muscle cells. The invention also concerns a composition comprising the isolated smooth muscular cells obtainable by said method as therapeutic principle designed for humans. The invention further concerns the use of the isolated smooth muscular cells for preparing a therapeutic composition designed to replace smooth muscular cells. In particular, the invention concerns the use of said isolated smooth muscular cells for treating ischemia, cancer or any disease requiring revascularization of damaged tissues. Finally, the invention concerns the use of said smooth muscular cells as vector for an active principle for preparing a therapeutic composition designed for humans requiring treatment with said active principle. | 2009-10-29 |
20090269311 | Method for treating multiple system atrophy - The present invention provides a method for treating multiple system atrophy, comprising administering a therapeutically effective amount of mesenchymal stem cells (MSCs) to a human in need thereof. Preferably, the administering is performed by an intra-arterial injection of said MSCs and one or more intravenous injections of said MSCs. | 2009-10-29 |
20090269312 | Methods, Systems, and Apparati for Cellular Therapeutic Agent Preparation and Delivery - Methods and devices for the preparation of a biological pharmaceutical composition outside of a classified environment, such as Biological Safety Cabinet type environment, are described. In one aspect of the present technology, a method is provided to prepare a biological pharmaceutical composition preferably in an area next to a patient's bedside or at a facility's pharmacy. The method comprises transferring an appropriate amount of a diluent from a diluent component into a mixing receptacle using a transfer device, connecting a pooling harness between a biological pharmaceutical component and the mixing receptacle, transferring a biological pharmaceutical composition through the pooling harness to the mixing receptacle, mixing the diluent and the biological pharmaceutical composition to form a biological pharmaceutical composition mixture and administering the biological pharmaceutical composition mixture to a patient for either flat based or weight based dosing needs. | 2009-10-29 |
20090269313 | ENCAPSULATION SYSTEM - An encapsulation system for use in the treatment of diabetes (Types 1 or 2, and LADA) are provided. The system has (1) a delivery vehicle comprising a selectively permeable membrane that allows passage of glucose, insulin and other nutrients through the membrane, but prevents large molecules such as antibodies or inflammatory cells from passing through the membrane; (2) a population of islet cells or insulin producing cells encapsulated by said membrane; and (3) a biological response modifier that may be in contact with the membrane or encapsulated by the membrane. Generally, the biological response modifier is a compound, including resolved enantiomers, diastereomers, tautomers, salts and solvates thereof, having the following formula: | 2009-10-29 |
20090269314 | HUMAN CARDIOVASCULAR PROGENITOR CELLS - The present invention provides populations of human cardiovascular progenitor cells, methods of making such cells, and methods of using the cells for production of populations of cardiovascular colonies and populations of cardiomyocytes. Methods of cardiomyocytes replacement therapy are also provided. | 2009-10-29 |
20090269315 | METHODS OF USING ADIPOSE TISSUE-DERIVED CELLS IN THE TREATMENT OF CARDIOVASCULAR CONDITIONS - Cells present in processed lipoaspirate tissue are used to treat patients, including patients with cardiovascular conditions, diseases or disorders. Methods of treating patients include processing adipose tissue to deliver a concentrated amount of stem cells obtained from the adipose tissue to a patient. The methods may be practiced in a closed system so that the stem cells are not exposed to an external environment prior to being administered to a patient. Accordingly, in a preferred method, cells present in processed lipoaspirate are placed directly into a recipient along with such additives necessary to promote, engender or support a therapeutic cardiovascular benefit. | 2009-10-29 |
20090269316 | Methods for Using a Three-Dimensional Stromal Tissue to Promote Angiogenesis - The present invention relates to a method for promoting blood vessel formation in tissues and organs. In particular, the method relates to implantation or attachment of an engineered three-dimensional stromal tissue to promote endothelialization and angiogenesis in the heart and related tissues. The three-dimensional stromal tissue of the present invention may be used in a variety of applications including, but not limited to, promoting repair of and regeneration of damaged cardiac muscle, promoting vascularization and healing during cardiac surgery, promoting blood vessel formation at anastomosis sites, and promoting vascularization and repair of damaged skeletal muscle, smooth muscle or connective tissue. | 2009-10-29 |
20090269317 | IRREVERSIBLE ELECTROPORATION TO CREATE TISSUE SCAFFOLDS - The present invention provides engineered tissue scaffolds, engineered tissues, and methods of using them. The scaffolds and tissues are derived from natural tissues and are created using non-thermal irreversible electroporation (IRE). Use of IRE allows for ablation of cells of the tissue to be treated, but allows vascular and neural structures to remain essentially unharmed. Use of IRE thus permits preparation of thick tissue scaffolds and tissues due to the presence of vasculature within the scaffolds. The engineered tissues can be used in methods of treating subjects, such as those in need of tissue replacement or augmentation. | 2009-10-29 |
20090269318 | PROGENITOR CELLS FROM WHARTON'S JELLY OF HUMAN UMBILICAL CORD - Human progenitor cells are extracted from perivascular tissue of human umbilical cord. The progenitor cell population proliferates rapidly, and harbours osteogenic progenitor cells and MHC−/− progenitor cells, and is useful to grow and repair human tissues including bone. | 2009-10-29 |
20090269319 | ARPE-19 as a Platform Cell Line for Encapsulated Cell-Based Delivery - ARPE-19 cells were evaluated as a platform cell line for encapsulated and unencapsulated cell-based delivery technology. ARPE-19 cells were found to be hardy (the cell line is viable under stringent conditions, such as in central nervous system or intra-ocular environment); can be genetically modified to secrete the protein of choice; have a long life span; are of human origin; have good in vivo device viability; deliver efficacious quantity of growth factor; trigger no or low level host immune reaction, and are non-tumorigenic. | 2009-10-29 |
20090269320 | VARIANTS OF PIGMENT EPITHELIUM DERIVED FACTOR AND USES THEREOF - The present invention provides anti-angiogenic variants of pigment epithelium derived factor (PEDF) comprising at least one altered phosphorylation site, polynucleotides encoding same and uses thereof. Particularly, the present invention provides variants of human PEDF comprising at least one amino acid substitution at serine residues (24), (114), and (227). The PEDF variants are potent anti-angiogenic factors, and thus useful in treating diseases or disorders associated with neovascularization. | 2009-10-29 |
20090269321 | Immune Function Modulating Agents - A probiotic | 2009-10-29 |
20090269322 | COMPOSITIONS COMPRISING SELENIUM-RICH YEAST AND YEAST BETA-GLUCAN - A nutritional composition comprising by weight: between 0.05 and 30% selenium-enriched yeast; between 1 and 90% yeast beta-glucan; between 0.5 and 60% Vitamin C; and between 0.5 and 40% Vitamin E. The composition features anti-oxidative, anti-aging, cancer-preventing, and immune-stimulating properties. | 2009-10-29 |
20090269323 | NON-AMPHIPHILE-BASED WATER-IN-WATER EMULSION AND USES THEREOF - The present invention relates to a non-amphiphile-based water-in-water emulsion composition. The non-amphiphile-based water-in-water emulsion composition includes a water-soluble polymer, a non-amphiphilic lyotropic mesogen encapsulated by the water-soluble polymer; and water. In one embodiment, the non-amphiphilic lyotropic mesogen includes, without limitation, a lyotropic chromonic liquid crystal, and more specifically disodium cromoglycate (DSCG). In another embodiment, the water-soluble polymer can include, without limitation, a polyacrylamide, a polyol, a polyvinylpyrrolidone, a polysaccharide, or a water-soluble fluoride-bearing polymer. The present invention also relates to a porous hydrogel made with the use of the non-amphiphile-based water-in-water emulsion. The present invention further relates to using the emulsion and hydrogel for various applications. | 2009-10-29 |
20090269324 | ANTIMICROBIAL PERACID COMPOSITIONS WITH SELECTED CATALASE ENZYMES AND METHODS OF USE IN ASEPTIC PACKAGING - The present invention relates to specially selected catalase enzymes and their use in reducing hydrogen peroxide in applications, and particularly in aseptic packaging applications. | 2009-10-29 |
20090269325 | Methods for treating bleeding disorders using sulfated polysaccharides - Methods for treating bleeding disorders using non-anticoagulant sulfated polysaccharides (NASPs) as procoagulants are disclosed. NASPs can be administered as single agents, or in combination with one another, or with other medications (such as factors VII, VIII and IX) to promote hemostasis. In particular, the use of NASPs in treatment of bleeding disorders, including congenital coagulation disorders, acquired coagulation disorders, and trauma induced hemorrhagic conditions is described. | 2009-10-29 |
20090269326 | Compositions of and methods of using sulfatases from flavobacterium heparinum - This invention is related, in part, to sulfatase enzymes and methods of their use. | 2009-10-29 |
20090269327 | Protein having prolyl oligopeptidase activity, nucleic acid encoding same and method for producing and using same - Proteins isolated from | 2009-10-29 |
20090269328 | Dry Composition for Oral Ingestion and Gel Composition Prepared Just Before Use for Oral Ingestion - A dry composition for oral ingestion characterized by comprising as an active ingredient a gas-releasing substance which releases gas by soak with water, and further comprising a gel base in an amount sufficient for gel formation; a gel composition for oral ingestion formed by adding water or a liquid diluent to the dry compound when taking; and a mixed feed obtainable by mixing the gel composition with a feed, are disclosed. | 2009-10-29 |
20090269329 | Combination Therapeutic products and systems - Combination therapeutics, computer program products, and systems are described that include at least one combined prescription psychiatric medication and at least one artificial sensory experience for treating a psychiatric disorder | 2009-10-29 |
20090269330 | FATTY ACID TRIGLYCERIDES FOR MAKING BIOCOMPATIBLE COATINGS - The invention relates to a mixture (a) of fatty acid triglycerides having a slip melting point above | 2009-10-29 |
20090269331 | CASPASE-8 AND INFLAMMATION, INFECTION AND WOUND HEALING - The present invention relates to the regulatory role of caspase-8 in infection by intracellular pathogen, inflammation and wound healing | 2009-10-29 |